NL113512C - - Google Patents

Info

Publication number
NL113512C
NL113512C NL113512DA NL113512C NL 113512 C NL113512 C NL 113512C NL 113512D A NL113512D A NL 113512DA NL 113512 C NL113512 C NL 113512C
Authority
NL
Netherlands
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication of NL113512C publication Critical patent/NL113512C/xx

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2/00Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
    • B01J2/28Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic using special binding agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/14Quaternary ammonium compounds, e.g. edrophonium, choline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/375Ascorbic acid, i.e. vitamin C; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/245Bismuth; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
NL113512D 1962-01-25 NL113512C (US06262066-20010717-C00203.png)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL273962 1962-01-25

Publications (1)

Publication Number Publication Date
NL113512C true NL113512C (US06262066-20010717-C00203.png)

Family

ID=19753562

Family Applications (2)

Application Number Title Priority Date Filing Date
NL113512D NL113512C (US06262066-20010717-C00203.png) 1962-01-25
NL273962D NL273962A (US06262066-20010717-C00203.png) 1962-01-25

Family Applications After (1)

Application Number Title Priority Date Filing Date
NL273962D NL273962A (US06262066-20010717-C00203.png) 1962-01-25

Country Status (9)

Country Link
US (1) US3266992A (US06262066-20010717-C00203.png)
BE (1) BE627516A (US06262066-20010717-C00203.png)
BR (1) BR6346422D0 (US06262066-20010717-C00203.png)
DE (1) DE1278699B (US06262066-20010717-C00203.png)
ES (1) ES284308A1 (US06262066-20010717-C00203.png)
FI (1) FI46028C (US06262066-20010717-C00203.png)
GB (1) GB1028792A (US06262066-20010717-C00203.png)
NL (2) NL273962A (US06262066-20010717-C00203.png)
SE (1) SE327048B (US06262066-20010717-C00203.png)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1467781A1 (de) * 1963-07-15 1968-12-05 Boehringer Sohn Ingelheim Verfahren zur Herstellung von Dragees mit verlaengerter Wirkstofffreigabe
US3388041A (en) * 1964-01-27 1968-06-11 Richardson Merrell Inc High dosage sustained release tablet
DE1228029C2 (de) * 1964-05-09 1973-05-17 Merck Ag E Verfahren zur Herstellung von Tabletten durch Pressen von Pulvergemischen ohne vorhergehende Granulation
US3459863A (en) * 1966-10-14 1969-08-05 Merck & Co Inc Color-stable ascorbic acid tablet
US3493659A (en) * 1967-10-23 1970-02-03 Hoffmann La Roche Compositions and process for the production thereof
NL159577B (nl) * 1968-02-15 1979-03-15 Organon Nv Werkwijze ter bereiding van snel desintegrerende vaste vormstukken.
US3627885A (en) * 1968-07-18 1971-12-14 Rit Rech Ind Therapeut Stabilized antibiotic compositions for animal feeding
US3725556A (en) * 1970-11-12 1973-04-03 D Hanssen Method of manufacturing rapidly disintegrating pharmaceutical tablets
GB1405088A (en) * 1971-06-03 1975-09-03 Mundipharma Ag Slow release formulation
US3965256A (en) * 1972-05-16 1976-06-22 Synergistics Slow release pharmaceutical compositions
JPS5438167B2 (US06262066-20010717-C00203.png) * 1974-04-27 1979-11-19
US3946110A (en) * 1974-05-30 1976-03-23 Peter, Strong Research And Development Company, Inc. Medicinal compositions and methods of preparing the same
US4097606A (en) * 1975-10-08 1978-06-27 Bristol-Myers Company APAP Tablet containing an alkali metal carboxymethylated starch and processes for manufacturing same
DE2551446B2 (de) * 1975-11-15 1977-09-15 Karl Werner Schlüter GmbH, 2000 Ham burg Verfahren zur herstellung von suppositorien
US4248856A (en) * 1979-07-10 1981-02-03 American Home Products Corporation Sustained release pharmaceutical compositions
US4309406A (en) * 1979-07-10 1982-01-05 American Home Products Corporation Sustained release pharmaceutical compositions
US4309405A (en) * 1979-08-09 1982-01-05 American Home Products Corporation Sustained release pharmaceutical compositions
US4309404A (en) * 1979-08-09 1982-01-05 American Home Products Corporation Sustained release pharmaceutical compositions
US4248858A (en) * 1979-08-09 1981-02-03 American Home Products Corporation Sustained release pharmaceutical compositions
US4248857A (en) * 1979-08-09 1981-02-03 American Home Products Corporation Sustained release pharmaceutical compositions
US4382919A (en) * 1980-09-15 1983-05-10 Bristol-Myers Company Composition for treatment and prevention of malodorous generating skin conditions
DE3266122D1 (en) * 1981-04-02 1985-10-17 Medichemie Ag Method for the preparation of moulded bodies for asepticizing water and aqueous solutions
EP0160087A4 (en) * 1983-10-24 1987-06-29 Basf Wyandotte Corp METHOD FOR PRODUCING SPRAY-DRIED POWDER, CONTAINING A WATER-SOLUBLE VITAMIN, AND POWDER PRODUCED THEREOF.
US4533674A (en) * 1983-10-24 1985-08-06 Basf Wyandotte Corporation Process for preparing a sugar and starch free spray-dried vitamin C powder containing 90 percent ascorbic acid
US4605666A (en) * 1983-10-24 1986-08-12 Basf Corporation Process for preparing spray-dried powders containing a water-soluble vitamin and powders prepared thereby
IT1235053B (it) * 1989-04-07 1992-06-17 Poli Ind Chimica Spa Metodi per la preparazione di composizioni farmaceutiche a base di bromocriptina dotate di elevata stabilita' e prodotti derivanti.
US6743443B1 (en) * 1998-10-05 2004-06-01 Eisai Co., Ltd. Tablets immediately disintegrating in the oral cavity

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2816062A (en) * 1954-05-27 1957-12-10 Univ Illinois Hydroxyethyl cellulose tablet coating
US2798838A (en) * 1954-11-10 1957-07-09 Smith Kline French Lab Method of preparing acetophenetidin tablets
DE1060093B (de) * 1957-04-26 1959-06-25 Ciba Geigy Neue Methode zur Herstellung eines Tablettengranulates
US2921883A (en) * 1957-05-03 1960-01-19 Smith Kline French Lab Novel coating material for medicaments
US3079303A (en) * 1958-12-11 1963-02-26 Smith Kline French Lab Basic tablet granulation and process of using same
NL270408A (US06262066-20010717-C00203.png) * 1960-10-20
US3116204A (en) * 1961-11-09 1963-12-31 Merck & Co Inc Pharmaceutical compositions and method of preparing the same

Also Published As

Publication number Publication date
BR6346422D0 (pt) 1973-08-02
FI46028C (fi) 1972-12-11
GB1028792A (en) 1966-05-11
DE1278699B (de) 1968-09-26
SE327048B (US06262066-20010717-C00203.png) 1970-08-10
BE627516A (US06262066-20010717-C00203.png)
NL273962A (US06262066-20010717-C00203.png)
FI46028B (US06262066-20010717-C00203.png) 1972-08-31
US3266992A (en) 1966-08-16
ES284308A1 (es) 1963-06-16

Similar Documents

Publication Publication Date Title
FI46028B (US06262066-20010717-C00203.png)
BE616548R (US06262066-20010717-C00203.png)
BE613108A (US06262066-20010717-C00203.png)
BE599783A (US06262066-20010717-C00203.png)
BE634972A (US06262066-20010717-C00203.png)
BE633905A (US06262066-20010717-C00203.png)
AU480751A (US06262066-20010717-C00203.png)
BE633106A (US06262066-20010717-C00203.png)
BE633102A (US06262066-20010717-C00203.png)
AU269855A (US06262066-20010717-C00203.png)
BE630273A (US06262066-20010717-C00203.png)
BE630163A (US06262066-20010717-C00203.png)
BE629165A (US06262066-20010717-C00203.png)
BE628824A (US06262066-20010717-C00203.png)
BE628582A (US06262066-20010717-C00203.png)
BE627851A (US06262066-20010717-C00203.png)
BE621626A (US06262066-20010717-C00203.png)
BE620271A (US06262066-20010717-C00203.png)
BE616785A (US06262066-20010717-C00203.png)
BE616490A (US06262066-20010717-C00203.png)
BE616386A (US06262066-20010717-C00203.png)
BE616166A (US06262066-20010717-C00203.png)
BE615962A (US06262066-20010717-C00203.png)
BE615849A (US06262066-20010717-C00203.png)
BE615804A (US06262066-20010717-C00203.png)